Attached files
| file | filename |
|---|---|
| 10-K - 10-K - ALBIREO PHARMA, INC. | albo-20191231x10k.htm |
| EX-31.2 - EX-31.2 - ALBIREO PHARMA, INC. | albo-20191231ex312352972.htm |
| EX-31.1 - EX-31.1 - ALBIREO PHARMA, INC. | albo-20191231ex3119fe54c.htm |
| EX-23.1 - EX-23.1 - ALBIREO PHARMA, INC. | albo-20191231ex231a7826d.htm |
| EX-21.1 - EX-21.1 - ALBIREO PHARMA, INC. | albo-20191231ex211169280.htm |
| EX-4.2 - EX-4.2 - ALBIREO PHARMA, INC. | albo-20191231ex429cef394.htm |
Exhibit 32.1
CERTIFICATIONS UNDER SECTION 906
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Albireo Pharma, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Annual Report for the year ended December 31, 2019 (the “Form 10-K”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Dated: March 2, 2020 |
/s/ Ronald H.W. Cooper |
|
|
Ronald H.W. Cooper |
|
|
President and Chief Executive Officer |
|
|
(principal executive officer) |
|
|
|
|
|
|
|
Dated: March 2, 2020 |
/s/ Simon N.R. Harford |
|
|
Simon N.R. Harford |
|
|
Chief Financial Officer and Treasurer |
|
|
(principal financial officer and principal accounting officer) |